Basics |
Company: |
Eli Lilly & Co. |
IPO Date: |
January 2, 1990 |
Sector: |
Healthcare |
Industry: |
Pharma |
Market Cap: |
$830.35B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$1.49 | 0.93%
|
Avg Daily Range (30 D): |
$12.07 | 1.51%
|
Avg Daily Range (90 D): |
$10.50 | 1.30%
|
Institutional Daily Volume |
Avg Daily Volume: |
4.38M |
Avg Daily Volume (30 D): |
3.15M |
Avg Daily Volume (90 D): |
3.1M |
Trade Size |
Avg Trade Size (Sh.): |
129 |
Avg Trade Size (Sh.) (30 D): |
30 |
Avg Trade Size (Sh.) (90 D): |
28 |
Institutional Trades |
Total Inst.Trades: |
84,843 |
Avg Inst. Trade: |
$8.24M |
Avg Inst. Trade (30 D): |
$70M |
Avg Inst. Trade (90 D): |
$69.17M |
Avg Inst. Trade Volume: |
.07M |
Avg Inst. Trades (Per Day): |
15 |
Market Closing Trades |
Avg Closing Trade: |
$74.84M |
Avg Closing Trade (30 D): |
$339.54M |
Avg Closing Trade (90 D): |
$349.97M |
Avg Closing Volume: |
419.98K |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$11.76
|
$4.9
|
$11.76
|
Diluted EPS
|
$11.71
|
$4.88
|
$11.71
|
Revenue
|
$ 45.04B
|
$ 13.53B
|
$ 45.04B
|
Gross Profit
|
$ 36.62B
|
$ 11.13B
|
$ 36.62B
|
Net Income / Loss
|
$ 10.59B
|
$ 4.41B
|
$ 10.59B
|
Operating Income / Loss
|
$ 12.68B
|
$ 5.04B
|
$ 12.68B
|
Cost of Revenue
|
$ 8.42B
|
$ 2.4B
|
$ 8.42B
|
Net Cash Flow
|
$ 449.8M
|
$ -100.6M
|
$ 449.8M
|
PE Ratio
|
74.49
|
|
|
|